Turning Point Therapeutics, Inc.
TPTXDelisted Aug 17, 2022- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001595893
Turning Point Therapeutics, Inc. was delisted on Aug 17, 2022; its insiders filed their last Form 4 on Aug 17, 2022; 209 institutions reported holding it in 13F filings for Q2 2022, worth $3.29B in total; Soros Fund Management was the only superinvestor holding it.
Q2 2021 vs. Q1 2021
How the institutions holding Turning Point Therapeutics, Inc. changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 202 | 190 | −12 |
| Shares | 44.4M | 46.0M | +1.54M (+3.5%) |
| Value | $4.21B | $3.59B | −$625.3M (−14.8%) |
New holders (26)
Institutions that held Turning Point Therapeutics, Inc. at the end of Q2 2021 but not at the end of Q1 2021.
Sold out (38)
Institutions that held Turning Point Therapeutics, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.